Skip to content
  • Home
  • About
Search
Close

MEDCOMMSNEWS

News, Views and Opinion – Headlines from the world of the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities

Data Transparency / Publications

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013

November 21, 2016November 28, 2016 Peter Llewellyn

From CMRO – [Read more]

Share this:

  • Twitter
  • Facebook

Like this:

Like Loading...

Related

Post navigation

Previous Post
The Trials Tracker and post-truth politics
Next Post
Lucid strengthens its creative services department

Specialist news and insights from: The Publication Plan for everyone interested in medical writing, the development of medical publications, and publication planning

How much can a single paper affect journal impact factor?

Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?

ISMPP poll: non-disclosure of possible COI by author ‒ what would you do?

CBI’s Medical Publications and Communications Forum

AMWA–EMWA–ISMPP joint position statement on predatory publishing

Archives

Index

Related service

MedComms Networking
MedComms Networking is a global initiative that facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities. Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.
Blog at WordPress.com.
Back to top
%d bloggers like this: